Respiratory Care Devices Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Respiratory Care Devices Market Dynamics

Technological Advancements Are Major Trends in Market

• Introduction of technologically advanced products in respiratory care device market have led to increase in functionality options for various respiratory care devices in home care and hospital settings.
• Various associated respiratory care devices are also increasingly being integrated to improve the quality of care in the long run.
• The advancement is majorly visible in IoT-connected respiratory monitoring devices, which continuously monitor the patients and send data on their condition in real time to the doctor.
• Just as the vitals drop to dangerous levels, the doctor can call the primary caretaker to intervene or send for an ambulance.
• A systematic review of the data over weeks or months also enables the doctor to modify the therapy and management protocols, as needed.
• This is a reflection of the rising demand for telemedicine and mHealth services, part of the wider growing trend of digital health.
• As per studies, global spending on telemedicine technologies and services will cross USD 144 billion by 2030, driven by the added convenience and HAI reduction potential of this approach.

Rising Respiratory Disease Burden Drives Market

• The rapid urbanization and increasing pollution level drive the prevalence of long-term diseases, which leads to an increase in the demand for respiratory care devices.
• According to the WHO, cities are home to over 55% of the world’s population, and this number is expected to increase to 68% by 2050.
• As a downside, the rapid urbanization of the environment and lifestyle has significantly threatened the health of individuals.
• Outdoor air pollution in cities and rural areas causes over 4 million premature deaths worldwide each year.
• The fine particulates emitted by the burning of fuel inside motor vehicles, domestic appliances, and industrial machinery are responsible for a range of cardiovascular conditions, cancers, and respiratory diseases.
• Moreover, the climate change due to air pollution has a considerable effect on health.
• In addition, the urban lifestyle is mostly sedentary, encourages the consumption of food with less nutritional benefits, and often leads to an absence of physical exercise.
  This can result in lower-quality pulmonary function, which further increases the chance of early mortality.
• According to the WHO estimates, more than 55% of the outdoor air pollution-related premature deaths are due to ischemic heart disease and strokes, a little over 5% due to lung cancer, and slightly under 20% due to chronic obstructive pulmonary disease or acute lower breathing infections.
• Tobacco use is one of the leading risks for mortality in the world due to long-term illnesses, such as cancer, lung diseases, and cardiovascular diseases.
• As per the WHO, every year, smoking is estimated to cause about 71% of the lung cancer, 42% of the COPD, and nearly 10% of the CVD cases.
• Moreover, 80% of the smokers worldwide live in low- and middle-income countries, leading to a high burden of tobacco-related illnesses and death here.
• Globally, the rate of tobacco usage and associated mortality are higher in men than women.
• Furthermore, 1.3 billion people regularly use tobacco around the world, and apart from affecting them, it also affects non-users, via second-hand smoke.
• More than 8 million people lose their lives due to tobacco consumption each year.
• Of these, 7 million deaths are the result of direct tobacco use, while around 1.2 million are the result of non-smokers being exposed to second-hand smoke.
• In order to detect and treat diseases attributed to the usage of tobacco, the usage of respiratory care devices continues to rise.

Strict Medical Device Regulations Hamper Market Growth

• The regulatory requirements for medical devices are vast, rapidly evolving, and mostly complicated due to legal technicalities.
• The safety, performance, and consistent quality of medical devices need stringent evaluation for public health.
• The medical device approval process is too stringent and time-consuming, which delays the commercialization of important new medical devices.
• In addition, it leads to an increase in the cost of research and development.
• The regulations and requirements also vary by country, specific product claims, intended use of device, and the level of risk involved.
• In the U.S., such regulations are implemented by the FDA, Safe Medical Device Act (SMDA), and the Clinical Laboratory Improvements Act (CLIA).
• The CLIA formulates regulations to set up, monitor, and validate new and existing medical devices, to ensure the accuracy, reliability, and timeliness of patient test results, regardless of the testing location.
• Before introducing a device in market, CLIA compliance is mandatory; therefore, gaining marketing approval for a device for a specific clinical indication in the U.S. is time-consuming and costly.
• Similarly, in Europe, the Medical Device Directives of the European Commission harmonize the law on safety and performance of medical devices sold within Europe.
• In the EU, the medical devices’ approval time is less than that in the U.S.; however, Russia has a complex and time-consuming process.

Segmentation Analysis

Insights by Type

In 2024, therapeutic devices accounted for the largest share, of over 60%, and they will also witness the highest CAGR. This is owed to the availability of a large number of therapeutic devices, such as humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, reusable resuscitators, ventilators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. They improve lung health by clearing the airway, increasing the lung oxygen intake capacity, and removing mucus.

The rising prevalence of respiratory disorders is the major driver for the category’s growth, with the increase in the number of operations propelling the demand for advanced therapeutic devices.

These types are analyzed:

• Therapeutic (Largest and Fastest-Growing Category)
  • Nitric oxide delivery units
  • Oxygen hoods
  • Nebulizers
  • Positive airway pressure (PAP) devices
  • Oxygen concentrators
  • Ventilators
    • Portable/transportable ventilators
    • ICU ventilators
  • Inhalers
  • Humidifiers
  • Resuscitators
  • Others
• Monitoring
  • Capnography devices
  • Gas analyzers
  • Pulse oximeters
  • Others
• Diagnostic
  • Spirometers
  • Polysomnography devices
  • Peak flow meters
  • Others

Insights by Indication

COPD held the largest share in the respiratory care devices market in 2024. This was due to an increase in the incidence of tobacco smoking and air pollution due to various other reasons. This category is also expected to witness the highest growth rate during the forecast period, of 8%, due to the high prevalence of COPD and the increasing number of deaths from it. More than 65 million people across the world have moderate-to-severe COPD, which makes breathing difficult, thus driving the demand for ventilators and inhalers.

These applications are analyzed:

• COPD (Largest and Fastest-Growing Category)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Others

Insights by End User

Hospitals accounted for the largest market share in 2024, of 55%. This was owing to the growing number of public–private partnerships to improve the access to healthcare services, along with the rapid developments in the healthcare infrastructure of emerging economies. The market dominance of this category is also because of the increasing number of such healthcare settings around the world. Moreover, most patients, especially with severe healthcare illnesses and sudden respiratory distress, are transported to hospitals as these places employ trained staff and boast the latest diagnostic, monitoring, and therapeutic equipment.

The homecare settings category is set to show the fastest growth during the forecast period owing to the rising adoption of home-based healthcare solutions and burgeoning aging population. Hospitalization increases the burden of healthcare cost; therefore, healthcare providers and government bodies are focusing on home healthcare. Respiratory care devices are increasingly being adopted for home healthcare. Different vendors are designing and developing equipment or devices for improved delivery of respiratory devices at lower cost in home healthcare.

The demand of home healthcare is increasing, especially since the pandemic, due to growing geriatric population, as it is the integral part of the primary healthcare service. Home healthcare provides older patients a better quality of life in their homes, limits the length of hospitalization, and provide more efficient treatment continuity monitoring for greater efficacy. The advancement in home automation, remote medical assistance and pharmacology facilitates the development of technologies such as respiratory assistance solutions; and infusion system, which assists the home delivery treatment for chronic disease patients.

These end users were analyzed:

• Hospitals (Largest and Fastest-Growing Category)
• Homecare Settings (Largest and Fastest-Growing Category)
• Emergency Centers
• Others

Respiratory Care Devices Market Geographical Analysis

In 2024, North America accounted for the largest share, of 40%, of the global revenue, with the rising incidence of respiration-related disorders driving the equipment demand. According to the CDC, 791,000 Americans with COPD as the primary diagnosis visited the emergency room in 2023.

Furthermore, over 480,000 deaths in the U.S. occur each year as a result of smoking cigarettes, among which 41,000 are caused by exposure to second-hand smoke. Moreover, an increase in the number of surgeries and breathing assistance procedures in the U.S., as a result of its aging population, will help the sector develop more.

Moreover, it is expected that as technology develops, the demand for therapeutic respiratory devices would rise. Further, manufacturers' involvement in patient care innovation, including the introduction of enhanced patient monitors, novel metrics, wireless machines, procedures, and integrated IT solutions, is escalating the demand. These innovations have enabled various anesthesiologists and physicians to offer individualized services to patients.

The Asia-Pacific (APAC) market is projected to develop at the highest CAGR during the forecast years, of 7.5%. This will majorly be due to the presence of a huge pool of respiratory patients, expanding medical service consumption, entry of new healthcare companies, rising per-capita income and working-class populace, and increasing commonness of tobacco smoking in this area. As per studies, with 316 million people, Chian has the largest customer base of tobacco products in the world. Moreover, India has at least 253 million regular users of tobacco products.

Additionally, APAC is advancing in technology, and it is being considered one of the most-lucrative regions for the corporate sector and electronic gadgets. The market growth in the region is also owing to the rising prevalence of chronic respiratory diseases, rapidly developing healthcare infrastructure, and rising healthcare expenditure. An estimated 43 million people in China have severe respiratory diseases, including COPD and asthma. Similarly, asthma affects over 35 million people in India, thus driving the demand for oxygen for the afflicted. Moreover, APAC is the fastest-growing market for medical devices, due to which it has become a medical tourism hub, which further intensifies the market growth.

The regions and countries were analyzed:

• North America (Largest Regional Market)
  • U.S. (Larger and Country Market)
  • Canada
• Europe
  • Germany (Largest Country Market)
  • U.K. (Fastest-Growing Country Market)
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • Japan
  • China (Largest Country Market)
  • India (Fastest-Growing Country Market)
  • South Korea
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest and Fastest-Growing Country Market)
  • Mexico
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa
  • U.A.E. (Fastest-Growing Country Market)
  • Rest of MEA

Respiratory Care Devices Market Share Analysis

• The market is consolidated as respiratory care devices are pieces of specialized medical equipment.
• This is why they require high technical prowess and financial to develop; they are also strongly regulated with a complex marketing approval process.
• Thus, only a handful of medical device companies that have been operating for a long time and possess enough lobbying power hold significant shares in the market.
• Additionally, most end users are hospitals, long-term care facilities, nursing homes, hospice centers, and diagnostic clinics, which only contract reputable medical device firms.
• In recent years, players in the respiratory care devices industry have been actively involved in mergers and acquisitions to improve their market position.

Respiratory Care Devices Market News & Updates

• In December 2024, Adherium entered into a partnership with Tenovi, under which the latter will integrate its Cellular Gateway technology into the former’s Hailie Smart inhalers. The integration will enable better remote monitoring of patients with chronic respiratory conditions.
• In October 2024, Masimo Corporation announced a pilot project for its Radius VSM at the emergency department of Vanderbilt UniversityMedical Center. Featuring Masimo’s Patient SafetyNets software for supplemental remote monitoring, this patient-worn vital signs monitor offers Masimo SET pulse oximetry, continuous temperature, measure-on-inflation noninvasive blood pressure, three-lead ECG, and respiration rate monitoring.
• In September 2024, ResMed Inc. launched the irTouch N30i tube-up CPAP nasal mask.
• In April 2024, Fisher & Paykel Healthcare Corporation Limited launched the F&P Nova Micro in New Zealand. This pillow mask for obstructive sleep apnea features the MicroPillows cushion and easily adjustable headgear.